US Patent 7855226 Treatment of inflammatory bowel disease
Patent 7855226 was granted and assigned to Allergan, Inc. on December, 2010 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 17, 2005
Date of Patent
December 21, 2010
Patent Application Number
11084454
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7855226 Treatment of inflammatory bowel disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.